Annals of Clinical Nutrition and Metabolism : eISSN 2799-8363 / pISSN 2799-7898
Table. 2.

Univariate analysis of factors associated with overall survival

Variable Categorization Univariate analysis
HR (95% CI) P-value
Sex Female 1
Male 1.205 (0.871–1.666) 0.26
Age (yr) <70 1
≥70 2.592 (1.895–3.546) <0.001
Diabetes mellitus No 1
Yes 1.041 (0.702–1.541) 0.843
Hypertension No 1
Yes 1.324 (0.968–1.811) 0.078
Smoking No 1
Yes 0.940 (0.668–1.323) 0.725
BMI (kg/m2) <25 1
≥25 0.575 (0.390–0.848) 0.005
CEA (ng/mL) <5 1
≥5 2.012 (1.456–2.781) <0.001
Unknown 1.044 (0.456–2.386) 0.919
Tumor location Colon 1
Rectum 0.913 (0.646–1.291) 0.608
Complications No 1
Yes 1.91 (1.372–2.658) <0.001
Histologic grade G1 & G2 1
G3 & MC & SRC 2.114 (1.347–3.317) 0.001
LVI Absent 1
Present 2.197 (1.559–3.096) <0.001
Unknown 1.331 (0.791–2.237) 0.281
Lymph nodes <12 1
≥12 0.657 (0.450–0.961) 0.03
Stage I 1
II 2.316 (1.287–4.169) 0.005
III 4.528 (2.630–7.795) <0.001
Chemotherapy No 1
Yes 0.859 (0.626–1.179) 0.347
Index year 2006–2009 1
2010–2014 0.573 (0.419–0.785) <0.001
SMI (cm2/m2) Low 1
High 0.544 (0.393–0.752) <0.001
SMD (HU) Low 1
High 0.384 (0.281–0.525) <0.001
Creatinine (mg/dL) Low 1
High 2.086 (1.523–2.858) <0.001
Combined groups G1 1
G2 2.446 (1.650–3.628) <0.001
G3 2.223 (1.453–3.401) <0.001
G4 3.702 (2.223–6.163) <0.001

HR = hazard ratio; CI = confidence interval; BMI = body mass index; CEA = carcinoembryonic antigen; G1 = no sarcopenia with low serum creatinine level; G2 = no sarcopenia with high serum creatinine levels; G3 = sarcopenia with low serum creatinine level; MC = mucinous adenocarcinoma; SRC = signet-ring cell; LVI = lymphovascular invasion; SMI = skeletal muscle index; SMD = skeletal muscle radiodensity; HU = Hounsfield unit; G4 = sarcopenia with high serum creatinine level.

Ann Clin Nutr Metab 2024;16:66-77 https://doi.org/10.15747/ACNM.2024.16.2.66
© 2024 Ann Clin Nutr Metab